Healthcare Global Enterprises growth over the years

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Compounded a year	1 yr	3 yr
Revenue	+14.5%	+14.5%
EBITDA	+20.3%	+16.0%
Net Income	−53.4%	+8.9%
EPS (adj.)	−69.0%	−22.3%
Total Assets	+10.7%	+19.2%
Total Equity	+42.5%	+17.5%
Free Cash Flow	−49.2%	−22.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HCG₹591.45

Healthcare Global Enterprises Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS RAINBOW JLHL CORONA MARKSANS METROPOLIS PARKHOSPSMcap ₹8,511 Cr

Annuals · FY-end closes

Compounded Growth Annuals · CAGR %	1Y CAGR	3Y CAGR
Revenue	+14.5	+14.5
EBITDA	+20.3	+16.0
Net Income	-53.4	+8.9
EPS (adj.)	-69.0	-22.3
Total Assets	+10.7	+19.2
Total Equity	+42.5	+17.5
Free Cash Flow	-49.2	-22.5

CAGR from filed annuals — needs positive start & end values.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.